These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7587718)
1. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs. Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718 [TBL] [Abstract][Full Text] [Related]
2. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050 [TBL] [Abstract][Full Text] [Related]
3. Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoprotein. Dordal MS; Jackson-Stone M; Ho AC; Winter JN; Atkinson AJ J Pharmacol Exp Ther; 1994 Dec; 271(3):1286-90. PubMed ID: 7996436 [TBL] [Abstract][Full Text] [Related]
4. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells? Denis-Gay M; Petit JM; Ratinaud MH Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620 [TBL] [Abstract][Full Text] [Related]
5. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance. Frey T; Yue S; Haugland RP Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707 [TBL] [Abstract][Full Text] [Related]
6. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093 [TBL] [Abstract][Full Text] [Related]
7. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041 [TBL] [Abstract][Full Text] [Related]
8. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells. Ghetie MA; Ghetie V; Vitetta ES Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321 [TBL] [Abstract][Full Text] [Related]
9. Reduced drug resistance in a multidrug resistant cell line by 5,8,11,14-eicosatetraynoic acid. Anderson KM; Harris JE Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):195-203. PubMed ID: 7881868 [TBL] [Abstract][Full Text] [Related]
10. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
11. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein. Lin JT; Sharma R; Grady JJ; Awasthi S Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
15. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine. Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423 [TBL] [Abstract][Full Text] [Related]
16. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098 [TBL] [Abstract][Full Text] [Related]
17. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920 [TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
19. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007 [TBL] [Abstract][Full Text] [Related]
20. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]